Objective measures of prenatal alcohol exposure: A systematic review

Pediatrics

Volumn 138, Issue 3, 2016, Pages

  McQuire, Cheryl ^a   Paranjothy, Shantini ^a   Hurt, Lisa ^a   Mann, Mala ^a   Farewell, Daniel ^a   Kemp, Alison ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; ETHYL GLUCURONIDE; ETHYL SULFATE; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN ACETALDEHYDE; PHOSPHATIDYLETHANOL; SULFATE; UNCLASSIFIED DRUG; ESTER; FATTY ACID;

ALCOHOL CONSUMPTION; BLOOD; BLOOD EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HAIR ANALYSIS; HUMAN; INFANT BLOOD; MATERNAL BLOOD; MEAN CORPUSCULAR VOLUME; MEASUREMENT; MECONIUM; PLACENTA; PREDICTIVE VALUE; PRENATAL ALCOHOL EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; URINALYSIS; VALIDITY; ALCOHOLISM; CHEMISTRY; DRINKING BEHAVIOR; FEMALE; FETAL ALCOHOL SYNDROME; FETOMATERNAL TRANSFUSION; HAIR; PREGNANCY; PROCEDURES; SUBSTANCE ABUSE;

ALCOHOL DRINKING; ALCOHOLISM; BIOMARKERS; ESTERS; FATTY ACIDS; FEMALE; FETAL ALCOHOL SPECTRUM DISORDERS; HAIR; HUMANS; MATERNAL-FETAL EXCHANGE; MECONIUM; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 84985987118     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-0517     Document Type: Review

References (115)

1. O'Keeffe LM, Kearney PM, McCarthy FP, et al. Prevalence and predictors of alcohol use during pregnancy: findings from international multicentre cohort studies. BMJ Open. 2015;5:e006323
2. Nykjaer C, Alwan NA, Greenwood DC, et al. Maternal alcohol intake prior to and during pregnancy and risk of adverse birth outcomes: evidence from a British cohort. J Epidemiol Community Health. 2014;68(6):542-549
3. Abel EL. Consumption of alcohol during pregnancy: a review of effects on growth and development of offspring. Hum Biol. 1982;54(3):421-453
4. Harlap S, Shiono PH. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet. 1980;2(8187):173-176
5. Mattson SN, Riley EP. A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res. 1998;22(2):279-294
6. Sokol RJ, Janisse JJ, Louis JM, et al. Extreme prematurity: an alcoholrelated birth effect. Alcohol Clin Exp Res. 2007;31(6):1031-1037
7. Sayal K, Heron J, Golding J, et al. Binge pattern of alcohol consumption during pregnancy and childhood mental health outcomes: longitudinal population-based study. Pediatrics. 2009;123(2). Available at: www.pediatrics.org/cgi/content/full/123/2/e289
8. O'Leary CM, Taylor C, Zubrick SR, Kurinczuk JJ, Bower C. Prenatal alcohol exposure and educational achievement in children aged 8-9 years. Pediatrics. 2013;132(2). Available at: www.pediatrics.org/cgi/content/full/132/2/e468
9. Roozen S, Peters G-JY, Kok G, Townend D, Nijhuis J, Curfs L. Worldwide prevalence of fetal alcohol spectrum disorders: a systematic literature review including meta-analysis. Alcohol Clin Exp Res. 2016;40(1):18-32
10. May PA, de Vries MM, Marais A-S, et al. The continuum of fetal alcohol spectrum disorders in four rural communities in South Africa: prevalence and characteristics. Drug Alcohol Depend. 2016;159:207-218
11. Henderson J, Gray R, Brocklehurst P. Systematic review of effects of lowmoderate prenatal alcohol exposure on pregnancy outcome. BJOG. 2007;114(3):243-252
12. O'Leary CM, Bower C. Guidelines for pregnancy: what's an acceptable risk, and how is the evidence (finally) shaping up? Drug Alcohol Rev. 2012;31(2):170-183
13. Flak AL, Su S, Bertrand J, Denny CH, Kesmodel US, Cogswell ME. The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: a meta-analysis. Alcohol Clin Exp Res. 2014;38(1):214-226
14. Mukherjee RAS, Hollins S, Abou-Saleh MT, Turk J. Low level alcohol consumption and the fetus. BMJ. 2005;330(7488):375-376
15. Mather M, Wiles K, O'Brien P. Should women abstain from alcohol throughout pregnancy? BMJ. 2015;351:h5232
16. von Hinke Kessler Scholder S, Wehby GL, Lewis S, Zuccolo L. Alcohol exposure in utero and child academic achievement. Econ J. 2014;124(576):634-667
17. Lewis SJ, Zuccolo L, Davey Smith G, et al. Fetal alcohol exposure and IQ at age 8: evidence from a populationbased birth-cohort study. PLoS One. 2012;7(11):e49407
18. Sood B, Delaney-Black V, Covington C, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect. Pediatrics. 2001;108(2). Available at: www.pediatrics.org/cgi/content/full/108/2/e34
19. Falgreen Eriksen HL, Mortensen EL, Kilburn T, et al. The effects of low to moderate prenatal alcohol exposure in early pregnancy on IQ in 5-year-old children. BJOG. 2012;119(10):1191-1200
20. Kesmodel US, Bertrand J, Støvring H, Skarpness B, Denny CH, Mortensen EL; Lifestyle During Pregnancy Study Group. The effect of different alcohol drinking patterns in early to mid pregnancy on the child's intelligence, attention, and executive function. BJOG. 2012;119(10):1180-1190
21. Skogerbø Å, Kesmodel US, Wimberley T, et al. The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on executive function in 5-year-old children. BJOG. 2012;119(10):1201-1210
22. Underbjerg M, Kesmodel US, Landrø NI, et al. The effects of low to moderate alcohol consumption and binge drinking in early pregnancy on selective and sustained attention in 5-year-old children. BJOG. 2012;119(10):1211-1221
23. Kelly YJ, Sacker A, Gray R, et al. Light drinking during pregnancy: still no increased risk for socioemotional difficulties or cognitive deficits at 5 years of age?. J Epidemiol Community Health. 2012;66(1):41-48
24. Kelly Y, Iacovou M, Quigley MA, et al. Light drinking versus abstinence in pregnancy - behavioural and cognitive outcomes in 7-year-old children: a longitudinal cohort study. BJOG. 2013;120(11):1340-1347
25. Kelly Y, Sacker A, Gray R, Kelly J, Wolke D, Quigley MA. Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age? Int J Epidemiol. 2009;38(1):129-140
26. Day NL, Leech SL, Richardson GA, Cornelius MD, Robles N, Larkby C. Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. Alcohol Clin Exp Res. 2002;26(10):1584-1591
27. Day NL, Richardson G, Robles N, et al. Effect of prenatal alcohol exposure on growth and morphology of offspring at 8 months of age. Pediatrics. 1990;85(5):748-752
28. Day NL, Zuo Y, Richardson GA, Goldschmidt L, Larkby CA, Cornelius MD. Prenatal alcohol use and offspring size at 10 years of age. Alcohol Clin Exp Res. 1999;23(5):863-869
29. O'Callaghan FV, O'Callaghan M, Najman JM, Williams GM, Bor W. Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: a longitudinal study. Early Hum Dev. 2003;71(2):137-148
30. Barr HM, Streissguth AP, Martin DC, Herman CS. Infant size at 8 months of age: relationship to maternal use of alcohol, nicotine, and caffeine during pregnancy. Pediatrics. 1984;74(3):336-341
31. O'Keeffe LM, Kearney PM, Greene RA, et al. Maternal alcohol use during pregnancy and offspring trajectories of height and weight: a prospective cohort study. Drug Alcohol Depend. 2015;153:323-329
32. Gray R. Low-to-moderate alcohol consumption during pregnancy and child development - moving beyond observational studies. BJOG. 2013;120(9):1039-1041
33. Astley S, Grant T. Another perspective on "the effect of different alcohol drinking patterns in early to mid pregnancy on the child's intelligence, attention, and executive function." BJOG. 2012;119(13):1672-1672
34. International Center for Alcohol Studies (ICAP). International guidelines on drinking and pregnancy. 2009. Available at: www.icap.org/table/InternationalDrinkingGuidelines.html. Accessed April 5, 2016
35. National Institute for Health and Care Excellence (NICE). Antenatal care for uncomplicated pregnancies (NICE Clinical Guideline 62); 2008. Available at: https://www.nice.org.uk/guidance/cg62. Accessed April 5, 2016
36. Department of Health. How to keep health risks from drinking alcohol to a low level: public consultation on proposed new guidelines. 2016. Available at: https://www.gov.uk/government/consultations/healthrisks-from-alcohol-new-guidelines. Accessed April 5, 2016
37. Russell M, Martier SS, Sokol RJ, Mudar P, Jacobson S, Jacobson J. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 1996;86(10):1435-1439
38. Jones TB, Bailey BA, Sokol RJ. Alcohol use in pregnancy: insights in screening and intervention for the clinician. Clin Obstet Gynecol. 2013;56(1):114-123
39. Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction. 2010;105(4):601-614
40. Muggli E, Cook B, O'Leary C, Forster D, Halliday J. Increasing accurate selfreport in surveys of pregnancy alcohol use. Midwifery. 2015;31(3):e23-e28
41. Ernhart CB, Morrow-Tlucak M, Sokol RJ, Martier S. Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res. 1988;12(4):506-511
42. Feunekes GI, van 't Veer P, van Staveren WA, Kok FJ. Alcohol intake assessment: the sober facts. Am J Epidemiol. 1999;150(1):105-112
43. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25(4):228-238
44. World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. 2014. Available at: www.who.int/substance-abuse/publications/pregnancy-guidelines/en. Accessed April 29, 2015
45. Astley SJ. Twenty years of patient surveys confirm a FASD 4-Digit-Code interdisciplinary diagnosis afforded substantial access to interventions that met patients' needs. J Popul Ther Clin Pharmacol. 2014;21(1):e81-e105
46. Reid N, Dawe S, Shelton D, et al. Systematic review of fetal alcohol spectrum disorder interventions across the life span. Alcohol Clin Exp Res. 2015;39(12):2283-2295
47. Astley SJ, Bailey D, Talbot C, Clarren SK. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: I. Identification of high-risk birth mothers through the diagnosis of their children. Alcohol Alcohol. 2000;35(5):499-508
48. Astley SJ, Bailey D, Talbot C, Clarren SK. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: II. A comprehensive profile of 80 birth mothers of children with FAS. Alcohol Alcohol. 2000;35(5):509-519
49. Bakhireva LN, Savage DD. Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. Alcohol Res Health. 2011;34(1):56-63
50. Bearer CF, Stoler JM, Cook JD, Carpenter SJ. Biomarkers of alcohol use in pregnancy. Alcohol Res Health. 2004-2005;28(1):38-43
51. Concheiro-Guisan A, Concheiro M. Bioanalysis during pregnancy: recent advances and novel sampling strategies. Bioanalysis. 2014;6(23):3133-3153
52. Joya X, Friguls B, Ortigosa S, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal. 2012;69:209-222
53. Littner Y, Bearer CF. Detection of alcohol consumption during pregnancy - current and future biomarkers. Neurosci Biobehav Rev. 2007;31(2):261-269
54. Memo L, Gnoato E, Caminiti S, Pichini S, Tarani L. Fetal alcohol spectrum disorders and fetal alcohol syndrome: the state of the art and new diagnostic tools. Early Hum Dev. 2013;89(suppl 1):S40-S43
55. Gifford AE, Bearer CF. Universal screening programs for gestational exposures. J Pediatr. 2015;166(3):522-524
56. Canadian Association of Paediatric Health Centres. Fetal alcohol spectrum disorder national screening tool kit 2014. Available at: http://ken.caphc.org/xwiki/bin/view/FASDScreeningToolkit/National+Screening+Tool+Kit+for+Children+and+Youth+Identified+and+Potentially+Affected+by+FASD. Accessed July 16, 2015
57. Deeks JJ, Bossuyt PM, Gatsonis C. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0.0. 2009. Available at: http://srdta.cochrane.org/. Accessed October 16, 2014
58. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138(1):W1-W12
59. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097
60. Burd L, Hofer R. Biomarkers for detection of prenatal alcohol exposure: a critical review of fatty acid ethyl esters in meconium. Birth Defects Res A Clin Mol Teratol. 2008;82(7):487-493
61. Chabenne A, Moon C, Ojo C, Khogali A, Nepal B, Sharma S. Biomarkers in fetal alcohol syndrome. Biomarkers and Genomic Medicine. 2014;6(1):12-22
62. Wurst FM, Alling C, Aradottir S, et al. Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res. 2005;29(3):465-473
63. Guidelines International Network (GIN). Templates of the evidence tables working group. 2014. Available at: www.g-i-n.net/working-groups/etwg/progresses-of-the-etwg. Accessed October 16, 2014
64. United States National Institute on Alcohol Abuse and Alcoholism. Alcohol use and alcohol use disorders in the United States, a 3-year follow-up: main findings from the 2004-2005 Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) (US Alcohol Epidemiologic Data Reference Manual Vol. 8, No. 2). Bethesda, MD: National Institutes of Health. 2010. Available at: http://pubs.niaaa.nih.gov/publications/datasys.htm. Accessed November 15, 2015
65. Whiting PF, Rutjes AW, Westwood ME, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536
66. Reitsma JBRA, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Assessing methodological quality. In: Deeks JJ BP, Gatsonis C, eds. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0.0. The Cochrane Collaboration: 2009; chapter 8. Available at: http://srdta.cochrane.org/. Accessed October 20, 2014
67. Higgins J, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Deeks JJ BP, Gatsonis C, eds. Cochrane handbook for systematic reviews of diagnostic test accuracy version 5.1.0. The Cochrane Collaboration: 2011; chapter 8. Available at: http://srdta.cochrane.org/. Accessed November 6, 2014
68. Stata Statistical Software: Release 13 [computer program]. College Station, TX: StataCorp LP; 2013
69. Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysing and presenting results. In: Deeks JJ BP, Gatsonis C., eds. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0. The Cochrane Collaboration: 2010; Chapter 10. Available at: http://srdta.cochrane.org/. Accessed November 6, 2014
70. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404-413
71. Koopman PAR. Confidence intervals for the ratio of two binomial proportions. Biometrics. 1984;40(2):513-517
72. Bakhireva LN, Leeman L, Savich RD, et al. The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure. Alcohol Clin Exp Res. 2014;38(4):1078-1085
73. Bearer CF, Jacobson JL, Jacobson SW, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003;143(4):463-469
74. Bearer CF, Lee S, Salvator AE, et al. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 1999;23(3):487-493
75. Bearer CF, Santiago LM, O'Riordan MA, Buck K, Lee SC, Singer LT. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr. 2005;146(6):824-830
76. Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25(3):271-278
77. Kwak HS, Han JY, Choi JS, et al. Doseresponse and time-response analysis of total fatty acid ethyl esters in meconium as a biomarker of prenatal alcohol exposure. Prenat Diagn. 2014a;34(9):831-838
78. Kwak HS, Han JY, Choi JS, et al. Characterization of phosphatidylethanol blood concentrations for screening alcohol consumption in early pregnancy. Clin Toxicol (Phila). 2014b;52(1):25-31
79. Ostrea EM Jr, Hernandez JD, Bielawski DM, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res. 2006;30(7):1152-1159
80. Sarkola T, Eriksson CJ, Niemelä O, Sillanaukee P, Halmesmäki E. Mean cell volume and gammaglutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand. 2000;79(5):359-366
81. Gauthier TW, Mohan SS, Gross TS, Harris FL, Guidot DM, Brown LAS. Placental fatty acid ethyl esters are elevated with maternal alcohol use in pregnancies complicated by prematurity. PLoS One. 2015;10(5):e0126552
82. Gutierrez HL, Hund L, Shrestha S, et al. Ethylglucuronide in maternal hair as a biomarker of prenatal alcohol exposure. Alcohol. 2015;49(6):617-623
83. Joya X, Marchei E, Salat-Batlle J, et al. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium. Clin Chem Lab Med. 2016;54(3): 427-435
84. Morini L, Marchei E, Tarani L, et al. Testing ethylglucuronide in maternal hair and nails for the assessment of fetal exposure to alcohol: comparison with meconium testing. Ther Drug Monit. 2013;35(3):402-407
85. Pichini S, Morini L, Pacifici R, et al. Development of a new immunoassay for the detection of ethyl glucuronide (EtG) in meconium: validation with authentic specimens analyzed using LC-MS/MS. Preliminary results. Clin Chem Lab Med. 2014;52(8):1179-1185
86. Morini L, Groppi A, Marchei E, et al. Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 Mediterranean cohorts. Ther Drug Monit. 2010;32(3):359-363
87. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006;174(4):469-476
88. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51(8):1335-1341
89. Whiting PF, Rutjes AW, Westwood ME, Mallett S; QUADAS-2 Steering Group. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol. 2013;66(10):1093-1104
90. Bossuyt PDC, Deeks J, Hyde C, Leeflang M, Scholten R. Interpreting results and drawing conclusions. In: Deeks JJBP, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.9. The Cochrane Collaboration; 2013; Chapter 11
91. Patra J, Bakker R, Irving H, Jaddoe VW, Malini S, Rehm J. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA) - a systematic review and meta-analyses. BJOG. 2011;118(12):1411-1421
92. Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ. 1994;309(6947):102
93. Zizzo N, Di Pietro N, Green C, Reynolds J, Bell E, Racine E. Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure. Alcohol Clin Exp Res. 2013;37(9):1451-1455
94. Marcellus L. Is meconium screening appropriate for universal use? Science and ethics say no. Adv Neonatal Care. 2007;7(4):207-214
95. Nicholls SG, Wilson BJ, Etchegary H, et al. Benefits and burdens of newborn screening: public understanding and decision-making. Personalized Medicine. 2014;11(6):593-607
96. Yan A, Bell E, Racine E. Ethical and social challenges in newborn screening for prenatal alcohol exposure. Can J Neurol Sci. 2014;41(1):115-118
97. Goldberger BA, Cone EJ, Kadehjian L. Unsuspected ethanol ingestion through soft drinks and flavored beverages. J Anal Toxicol. 1996;20(5):332-333
98. Reisfield GM, Goldberger BA, Crews BO, et al. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanolbased hand sanitizer. J Anal Toxicol. 2011;35(2):85-91
99. Reisfield GM, Goldberger BA, Pesce AJ, et al. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash. J Anal Toxicol. 2011;35(5):264-268
100. Musshoff F, Albermann E, Madea B. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods - misleading results? Int J Legal Med. 2010;124(6):623-630
101. Logan BK, Distefano S. Ethanol content of various foods and soft drinks and their potential for interference with a breath-alcohol test. J Anal Toxicol. 1998;22(3):181-183
102. Magnusson A, Göransson M, Heilig M. Unexpectedly high prevalence of alcohol use among pregnant Swedish women: failed detection by antenatal care and simple tools that improve detection. J Stud Alcohol. 2005;66(2):157-164
103. Lange S, Shield K, Koren G, Rehm J, Popova S. A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth. 2014;14:127
104. Zhou X-H, McClish DK, Obuchowski NA. Statistical Methods in Diagnostic Medicine. Vol 569. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2011
105. UK National Screening Committee (NSC). Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2013. Available at: www.screening.nhs.uk/criteria. Accessed November 7, 2014
106. Wilson J, Junger G. Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization; 1968. Public Health Papers 34
107. Bakhireva LN, Savich RD, Raisch DW, et al. The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots. Alcohol Clin Exp Res. 2013;37(6):1008-1015
108. Zelner I, Shor S, Lynn H, et al. Neonatal screening for prenatal alcohol exposure: assessment of voluntary maternal participation in an open meconium screening program. Alcohol. 2012;46(3):269-276
109. May PA, Blankenship J, Marais A-S, et al. Maternal alcohol consumption producing fetal alcohol spectrum disorders (FASD): quantity, frequency, and timing of drinking. Drug Alcohol Depend. 2013;133(2):502-512
110. Feldman HS, Jones KL, Lindsay S, et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res. 2012;36(4):670-676
111. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess. 2007;11(50):iii, ix-51
112. Peterson J, Kirchner HL, Xue W, Minnes S, Singer LT, Bearer CF. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J Pediatr. 2008;152(6):788-792
113. Min MO, Singer LT, Minnes S, Wu M, Bearer CF. Association of fatty acid ethyl esters in meconium and cognitive development during childhood and adolescence. J Pediatr. 2015;166(4):1042-1047
114. Caprara DL, Brien JF, Iqbal U, Reynolds JN, Klein J, Koren G. A Guinea pig model for the identification of in utero alcohol exposure using fatty acid ethyl esters in neonatal hair. Pediatr Res. 2005;58(6):1158-1163
115. Zelner I, Kenna K, Brien JF, et al. Meconium fatty acid ethyl esters as biomarkers of late gestational ethanol exposure and indicator of ethanolinduced multi-organ injury in fetal sheep. PLoS One. 2013;8(3):e59168